Physician profile
Charles E Cook
NPI 1417967928
$92,195.80
in general payments reported to CMS, 2019-2025
23 companies · $5,729 in 2025
The $5,729 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,144 · 2020: $1,190 · 2021: $7,954 · 2022: $53K · 2023: $11K · 2024: $6,751 · 2025: $5,729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $15K · Acquisitions: $6,194 · Food and Beverage: $2,214 · Travel and Lodging: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $14,751.00 |
| Acquisitions | $6,193.84 |
| Food and Beverage | $2,213.64 |
| Travel and Lodging | $782.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $61,156.48 | 2019-2024 | Avenger Radial Head, +4 Stems, Colink Mfx, Biobrace 23mm |
| Extremity Medical | $23,089.10 | 2019-2025 | Io Freedom, Carpalfix |
| Arthrex, INC. | $2,000.00 | 2019 | |
| 4web, INC. | $1,041.25 | 2019-2023 | Osteotomy Truss System |
| Stryker Corporation | $790.86 | 2022-2025 | Inbone, Augment Injectable, Citrefix |
| Integra Lifesciences Corporation | $666.01 | 2019-2020 | |
| In2bones USA, LLC | $641.90 | 2019-2021 | |
| Smith+Nephew, INC. | $504.10 | 2021-2025 | Salto Talaris Total Ankle Prosthesis, Evos |
| Pylant Medical | $497.20 | 2019-2025 | |
| Medline Industries LP | $413.02 | 2020-2022 | |
| Restor3d, INC. | $345.95 | 2024 | |
| Wright Medical Technology, INC. | $267.29 | 2020 | |
| Ossio INC | $166.58 | 2021 | |
| Bioventus LLC | $160.27 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Davol INC. | $131.74 | 2025 | Surgiphor |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $130.03 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $80.11 | 2022-2025 | Freestyle Libre 3 |
| Horizon Therapeutics Plc | $44.19 | 2019-2021 | |
| Orthofix Medical, INC. | $23.28 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $17.93 | 2025 | Exparel |
| Tolmar, INC. | $15.85 | 2025 | Jatenzo |
| Acera Surgical, INC. | $12.66 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$700,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.